CYMBELINE CULIAT
Chief Science Officer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Cymbelin Culiat is the Chief Science Officer at NellOne Therapeutics Inc. in the United States. With a focus on the treatment of osteoporotic bone loss and the genetic analysis of the microbiome, Dr. Culiat's recent work contributes to advancing knowledge in both bone health and microbiome research. Her publications reflect a commitment to integrating scientific inquiry with therapeutic innovation.
Articles (2)
Year:
2021
Year:
2020
Collaborators (1)
Rachael Hageman Blair
-
UNITED STATES
Make your next move.
Prepare your application
Review drafts before you send them.